UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) January 22, 2018

                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
               (Exact name of registrant as specified in charter)

                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)

                            301 Commercial Road, Unit D
      000-54582                  Golden, CO 80401           46-5221947
  -----------------      ------------------------------   ------------------
 (Commission File      (Address of Principal Executive   (IRS Employer
       Number)                 Offices and Zip Code       Identification Number)

                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)


                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
     CFR 240.14a-12(b))

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company [ ]

If an emerging  growth  company,  indicate by check mark if the  registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. [ ]

                                       1
<PAGE>

ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

     On January 24,  2018 the Company  entered  into a  non-exclusive  licensing
agreement with an affiliate of Harborside Health Association LLC.

     The license provided Harborside with the rights to the Company's technology
which will enable  Harborside to manufacture and distribute its proprietary line
of products.  In consideration for the license,  Harborside will pay the Company
the greater of:

     o    5% of the gross price paid by Harborside  for the  manufacture  of the
          products; or

     o    2.5% of the wholesale  price  received by Harborside  from the sale of
          the products.

     For purposes of the agreement,  the "wholesale price" for any product means
the gross price obtained by a distributor  licensed by Harborside  from the sale
of any  products in an arm's length  transaction  with  another  distributor  or
retailer,  excluding cannabis tax payments for remittance to taxing authorities;
and,  for  non-arm's  length  sales,  the  average  price  which could have been
obtained in an arm's length transaction.

     The technology licensed to Harborside covers the Company's patented methods
of extracting, preparing and using cannabis.

     The agreement has a term of three years.





                                       2
<PAGE>



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                      UNITED CANNABIS CORPORATION


Dated:  January 26, 2018              By: /s/ Chad Ruby
                                          ------------------------------------
                                          Chad Ruby
                                          Chief Operating Officer
[{"type": "8-K", "sequence": "1", "filename": "form8k101reharborside1-18.txt", "description": "FORM 8-K ITEM 1.01", "secsgml_size_bytes": 4357}]
{"company-data": {"conformed-name": "United Cannabis Corp", "cik": "0001436161", "assigned-sic": "2834", "irs-number": "261391338", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54582", "film-number": "18553179"}, "business-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "844-278-2420"}, "mail-address": {"street1": "1600 BROADWAY", "street2": "SUITE 1600", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "MySkin, Inc.", "date-changed": "20080528"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) January 22, 2018

                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
               (Exact name of registrant as specified in charter)

                                    Colorado
                ------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)

                            301 Commercial Road, Unit D
      000-54582                  Golden, CO 80401           46-5221947
  -----------------      ------------------------------   ------------------
 (Commission File      (Address of Principal Executive   (IRS Employer
       Number)                 Offices and Zip Code       Identification Number)

                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
     CFR 240.14a-12(b))

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company [ ]

If an emerging  growth  company,  indicate by check mark if the  registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. [ ]

                                       1
ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

     On January 24,  2018 the Company  entered  into a  non-exclusive  licensing
agreement with an affiliate of Harborside Health Association LLC.

     The license provided Harborside with the rights to the Company's technology
which will enable  Harborside to manufacture and distribute its proprietary line
of products.  In consideration for the license,  Harborside will pay the Company
the greater of:

     o    5% of the gross price paid by Harborside  for the  manufacture  of the
          products; or

     o    2.5% of the wholesale  price  received by Harborside  from the sale of
          the products.

     For purposes of the agreement,  the "wholesale price" for any product means
the gross price obtained by a distributor  licensed by Harborside  from the sale
of any  products in an arm's length  transaction  with  another  distributor  or
retailer,  excluding cannabis tax payments for remittance to taxing authorities;
and,  for  non-arm's  length  sales,  the  average  price  which could have been
obtained in an arm's length transaction.

     The technology licensed to Harborside covers the Company's patented methods
of extracting, preparing and using cannabis.

     The agreement has a term of three years.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                      UNITED CANNABIS CORPORATION

Dated:  January 26, 2018              By: /s/ Chad Ruby
                                          ------------------------------------
                                          Chad Ruby
                                          Chief Operating Officer